Equity
€199,942 ▲ 174%
Equity rose in 2025 from €72,979 to €199,942.
ENT
Lifetime
20 annual accounts with figures on one time axis, 21 filings since 2005peak €443,884 (2012)
€254,849▲ 15.1%
lowest -€91,204 (2013)
€126,964▲ €156,963
peak €282,226 (2017)
€199,942▲ 174%
€667,340▼ 14.0%
peak 2 FTE (2017)
-not published
Board1 name since 2021
1 director
Documentsfilings and deeds
29-10-202690 days late
2025micro format
Turnover from €221,428 to €254,849Gross margin from €102,260 to €252,281Back to profit: €126,964Equity from €72,979 to €199,942
Key points
from the 2025 annual accountsPayment terms
31 days to suppliers
ENT pays its suppliers 20 days earlier than in 2024. Customers pay 38 days later.
Filings
21 annual accounts 90 days
Latest accounts filed late: after the legal deadline.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Reappointment: (director)
General meeting of 05-12-2023 · Gazette deed
Incorporation
published on 26-04-2005 · Gazette deed
First establishment
Krokussenlaan 11, Anderlecht
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ENT Anderlecht | €867,282 | €252,281 | 23.1% | - |
| DOCTEUR SERGIO SICILIANO Ixelles | €821,847 | €254,174 | 68.8% | - |
| DOCTEUR PASCAL THUMILAIRE Uccle | €862,700 | €264,295 | 82.9% | - |
| DR. PETER MEEUS Brussels | €858,129 | €270,778 | 94.4% | - |
| PJOUKOVS Woluwe-Saint-Pierre | €847,901 | €234,823 | 52.7% | - |
| ALTAWAB KOCA MEDICAL CARE Schaerbeek | €872,376 | €277,921 | 62.4% | - |
| VINCENT MUSTIN, ORL Ixelles | €885,849 | €227,897 | 62.8% | - |
These companies have the same main activity as ENT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €822,000 and €886,000, founded between 2003 and 2006.
Official details
Source: KBO- Status
- Active since 18-04-2005Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Joint committee
- 330Health institutions and services · annual accounts 2024
- Establishment unit
- 2.229.496.3021070 Anderlecht, since 18-04-2005
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on ENT
ENT has existed since 2005. Turnover fell from €392,335 in 2006 to €254,849 in 2025.
Solvency rose in 2025 from 8.6% to 23.1% because of the retained profit and lower debts.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ENT
- What is the company number of ENT?
- The company number of ENT is 0873.263.185. The VAT number is the same number with BE in front: BE 0873.263.185.
- Where is ENT based?
- The registered office is at Krokussenlaan 11, 1070 Anderlecht.Company details
- What does ENT do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of ENT?
- ENT is a private limited company (BV).
- When was ENT founded?
- ENT was founded on 18-04-2005.
- Is ENT still active?
- Yes, ENT is an active enterprise in the KBO register.
- How many employees does ENT have?
- ENT had an average of 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does ENT fall under?
- In its 2024 annual accounts, ENT states joint committee 330 (Health institutions and services).
- What is the turnover of ENT?
- The turnover of ENT was €254,849 in financial year 2025, according to the filed annual accounts.
- Is ENT profitable?
- In financial year 2025, ENT made a profit of €126,964.
- Where can I find the annual accounts of ENT?
- ENT filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ENT due?
- ENT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.